logo-loader

Instem eyes further growth following upbeat results

Published: 04:32 01 Apr 2019 EDT

Phil Reason, CEO of Instem PLC (LON:INS.L) said the company will continue to focus on growth after a pleasing year for Instem in addition to considering “complementary acquisition targets”. Reason talks to Proactive London about the publication of Instem's full-year results, which showed turnover grew 8% to £22.7mln; around a quarter of that number coming in the form of higher-margin, recurring software-as-a-service (SaaS) revenues. News here too on growth in Asia Pacific markets and technology-enabled outsourcing services pushed by Instem this year.

Instem Plc 'very positive about 2017 clinical opportunites'

Instem Plc (LON:INS) said the performance of its clinical arm had further deteriorated since it last updated and will fall “materially short” of its financial targets. The remainder of the business, which provides analytical software to drug developers, has seen “increased...

on 11/23/2016